Patient selection for TAVI in 2014: Is there a justification for treating low- or intermediate-risk patients? the surgeon's view

EuroIntervention

Volumn 10, Issue , 2014, Pages U11-U15

  Kappetein, Arie Pieter ^a   Osnabrugge, Ruben L J ^a   Head, Stuart J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Aortic stenosis; Risk category; Surgical aortic valve replacement; Transcatheter aortic valve implantation

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ANTICOAGULANT THERAPY; AORTA BALLOON; AORTA VALVE; AORTA VALVE REGURGITATION; AORTA VALVE STENOSIS; BICUSPID AORTIC VALVE; BIOPROSTHESIS; BLEEDING; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY OBSTRUCTION; COST EFFECTIVENESS ANALYSIS; DEMENTIA; DEVICE FAILURE; DISEASE SEVERITY; ENDOCARDITIS; HEART CONDUCTION; HEART MUSCLE INJURY; HUMAN; INTERMEDIATE RISK PATIENT; LOADING DRUG DOSE; LOW RISK PATIENT; MITRAL VALVE; MITRAL VALVE REGURGITATION; PACEMAKER IMPLANTATION; PATIENT SELECTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; AORTIC VALVE STENOSIS; ENDOVASCULAR SURGERY; THORAX SURGERY; TRENDS;

AORTIC VALVE STENOSIS; ENDOVASCULAR PROCEDURES; HUMANS; PATIENT SELECTION; THORACIC SURGERY; TRANSCATHETER AORTIC VALVE REPLACEMENT;

EID: 84907524430     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV10SUA2     Document Type: Review

References (31)

1. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Lung B, Lancellotti P, Pierard L, Price S, Schäfers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2012;42:S1-44.
2. Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Buchbinder M, Hermiller J, Kleiman NS, Chetcuti S, Heiser J, Merhi W, Zorn G, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Conte J, Maini B, Mumtaz M, Chenoweth S, Oh JK. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370:1790-8.
3. Svensson LG, Blackstone EH, Rajeswaran J, Brozzi N, Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Tuzcu EM, Webb JG, Kapadia S, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Thourani VH, Pichard AD, Bavaria JE, Herrmann HC, Williams MR, Babaliaros V, Généreux P, Akin JJ; PARTNER Trial Investigators. Comprehensive Analysis of Mortality Among Patients Undergoing TAVR. J Am Coll Cardiol. 2014;64:158-68.
4. Osnabrugge RL, Speir AM, Head SJ, Fonner CE, Fonner E, Kappetein AP, Rich JB. Performance of EuroSCORE II in a large US database: implications for transcatheter aortic valve implantation. Eur J Cardiothorac Surg. 2014;46:400-8.
5. Van Mieghem NM, Serruys PW. The art of risk stratification in TAVI. Eur Heart J. 2013;34:1859-61.
6. Osnabrugge RL, Speir AM, Head SJ, Fonner CE, Fonner E, Ailawadi G, Kappetein AP, Rich JB. Costs for surgical aortic valve replacement according to preoperative risk categories. Ann Thorac Surg. 2013;96:500-6.
7. Dvir D, Webb JG, Bleiziffer S, Pasic M, Waksman R, Kodali S, Barbanti M, Latib A, Schaefer U, Rodés-Cabau J, Treede H, Piazza N, Hildick-Smith D, Himbert D, Walther T, Hengstenberg C, Nissen H, Bekeredjian R, Presbitero P, Ferrari E, Segev A, de Weger A, Windecker S, Moat NE, Napodano M, Wilbring M, Cerillo AG, Brecker S, Tchetche D, Lefévre T, De Marco F, Fiorina C, Petronio AS, Teles RC, Testa L, Laborde JC, Leon MB, Kornowski R. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA. 2014;312:162-70.
8. Head SJ, Mokhles MM, Osnabrugge RL, Pibarot P, Mack MJ, Takkenberg JJ, Bogers AJ, Kappetein AP. The impact of prosthesis-patient mismatch on long-term survival after aortic valve replacement: a systematic review and meta-Analysis of 34 observational studies comprising 27 186 patients with 133 141 patient-years. Eur Heart J. 2012;33:1518-29.
9. Wijesinghe N, Ye J, Rodés-Cabau J, Cheung A, Velianou JL, Natarajan MK, Dumont E, Nietlispach F, Gurvitch R, Wood DA, Tay E, Webb JG. Transcatheter aortic valve implantation in patients with bicuspid aortic valve stenosis. JACC Cardiovasc Interv. 2010;3:1122-5.
10. Roy DA, Schaefer U, Guetta V, Hildick-Smith D, Möllmann H, Dumonteil N, Modine T, Bosmans J, Petronio AS, Moat N, Linke A, Moris C, Champagnac D, Parma R, Ochala A, Medvedofsky D, Patterson T, Woitek F, Jahangiri M, Laborde JC, Brecker SJ. Transcatheter aortic valve implantation for pure severe native aortic valve regurgitation. J Am Coll Cardiol. 2013;61:1577-84.
11. Seiffert M, Diemert P, Koschyk D, Schirmer J, Conradi L, Schnabel R, Blankenberg S, Reichenspurner H, Baldus S, Treede H. Transapical implantation of a second-generation transcatheter heart valve in patients with noncalcified aortic regurgitation. JACC Cardiovasc Interv. 2013;6:590-7.
12. Lerakis S, Hayek SS, Douglas PS. Paravalvular aortic leak after transcatheter aortic valve replacement: current knowledge. Circulation. 2013;127:397-407.
13. Généreux P, Head SJ, Hahn R, Daneault B, Kodali S, Williams MR, van Mieghem NM, Alu MC, Serruys PW, Kappetein AP, Leon MB. Paravalvular leak after transcatheter aortic valve replacement: the new Achilles'heel? A comprehensive review of the literature. J Am Coll Cardiol. 2013;61:1125-36.
14. Généreux P, Head SJ, Van Mieghem NM, Kodali S, Kirtane AJ, Xu K, Smith C, Serruys PW, Kappetein AP, Leon MB. Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-Analysis of 3,519 patients from 16 studies. J Am Coll Cardiol. 2012;59:2317-26.
15. Kim WK, Rolf A, Liebetrau C, Van Linden A, Blumenstein J, Kempfert J, Bachmann G, Nef H, Hamm C, Walther T, Möllmann H. Detection of Myocardial Injury by CMR After Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2014;64:349-57.
16. Van Mieghem NM, Head SJ, de Jong W, van Domburg RT, Serruys PW, de Jaegere PP, Jordaens L, Takkenberg JJ, Bogers AJ, Kappetein AP. Persistent annual permanent pacemaker implantation rate after surgical aortic valve replacement in patients with severe aortic stenosis. Ann Thorac Surg. 2012;94:1143-9.
17. Biner S, Michowitz Y, Leshem-Rubinow E, Topilsky Y, Ben-Assa E, Shimiaie J, Banai S, Keren G, Steinvil A, Finkelstein A. Hemodynamic impact and outcome of permanent pacemaker implantation following transcatheter aortic valve implantation. Am J Cardiol. 2014;113:132-7.
18. Khatri PJ, Webb JG, Rodés-Cabau J, Fremes SE, Ruel M, Lau K, Guo H, Wijeysundera HC, Ko DT. Adverse effects associated with transcatheter aortic valve implantation: a meta-Analysis of contemporary studies. Ann Intern Med. 2013;158:35-46.
19. Van Mieghem NM, Généreux P, van der Boon RM, Kodali S, Head S, Williams M, Daneault B, Kappetein AP, de Jaegere PP, Leon MB, Serruys PW. Transcatheter aortic valve replacement and vascular complications definitions. EuroIntervention. 2014;9:1317-22.
20. Généreux P, Webb JG, Svensson LG, Kodali SK, Satler LF, Fearon WF, Davidson CJ, Eisenhauer AC, Makkar RR, Bergman GW, Babaliaros V, Bavaria JE, Velazquez OC, Williams MR, Hueter I, Xu K, Leon MB. Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. J Am Coll Cardiol. 2012;60:1043-52.
21. Waksman R, Minha S. Stroke after aortic valve replacement: the known and unknown. Circulation. 2014;129:2245-7.
22. Wong DR, Boone RH, Thompson CR, Allard MF, Altwegg L, Carere RG, Cheung A, Ye J, Lichtenstein SV, Ling H, Webb JG. Mitral valve injury late after transcatheter aortic valve implantation. J Thorac Cardiovasc Surg. 2009;137:1547-9.
23. Piazza N, Marra S, Webb J, D'Amico M, Rinaldi M, Boffini M, Comoglio C, Scacciatella P, Kappetein AP, de Jaegere P, Serruys PW. Two cases of aneurysm of the anterior mitral valve leaflet associated with transcatheter aortic valve endocarditis: a mere coincidence? J Thorac Cardiovasc Surg. 2010;140:e36-8.
24. Rodés-Cabau J, Dauerman HL, Cohen MG, Mehran R, Small EM, Smyth SS, Costa MA, Mega JL, O'Donoghue ML, Ohman EM, Becker RC. Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events. J Am Coll Cardiol. 2013;62:2349-59.
25. Toggweiler S, Humphries KH, Lee M, Binder RK, Moss RR, Freeman M, Ye J, Cheung A, Wood DA, Webb JG. 5-year outcome after transcatheter aortic valve implantation. J Am Coll Cardiol. 2013;61:413-9.
26. Rodés-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Osten M, Feindel CM, Natarajan MK, Velianou JL, Martucci G, DeVarennes B, Chisholm R, Peterson M, Thompson CR, Wood D, Toggweiler S, Gurvitch R, Lichtenstein SV, Doyle D, DeLarochelliére R, Teoh K, Chu V, Bainey K, Lachapelle K, Cheema A, Latter D, Dumesnil JG, Pibarot P, Horlick E. Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience. J Am Coll Cardiol. 2012;60:1864-75.
27. Alavi SH, Groves EM, Kheradvar A. The effects of transcatheter valve crimping on pericardial leaflets. Ann Thorac Surg. 2014;97:1260-6.
28. Reynolds MR, Magnuson EA, Lei Y, Wang K, Vilain K, Li H, Walczak J, Pinto DS, Thourani VH, Svensson LG, Mack MJ, Miller DC, Satler LE, Bavaria J, Smith CR, Leon MB, Cohen DJ; PARTNER Investigators. Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A). J Am Coll Cardiol. 2012;60:2683-92.
29. Osnabrugge RL, Kappetein AP, Reynolds MR, Cohen DJ. Cost-effectiveness of transcatheter valvular interventions: economic challenges. EuroIntervention. 2013;9 Suppl:S48-54.
30. Osnabrugge RL, Head SJ, Genders TS, Van Mieghem NM, De Jaegere PP, van der Boon RM, Kerkvliet JM, Kalesan B, Bogers AJ, Kappetein AP, Hunink MG . Costs of transcatheter versus surgical aortic valve replacement in intermediate-risk patients. Ann Thorac Surg. 2012;94:1954-60.
31. Kappetein AP, Feldman TE, Mack MJ, Morice MC, Holmes DR, Ståhle E, Dawkins KD, Mohr FW, Serruys PW, Colombo A. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J. 2011;32:2125-34.